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Experimental section
Materials. hCAII was purchased from Sigma-Aldrich. N-methylpyrrolidone (NMP), diethylether, dichloromethane (DCM) and Fmoc-γ-Abu-OH (GABA) were purchased from Merck. Fmoc-protected D-amino acids (Fmoc-AAs) were purchased from GL Biochem Ltd (Shanghai, China). TentaGel S amino resin was purchased from Rapp Polymere. α-Cyano-4-hydroxycinnamic acid (CHCA) was purchased from Bruker. EZ-Link NHS-Biotin reagent was purchased from Thermo Scientific. hCAII (Aldrich), bCAII (Aldrich), PSA (Fitzgerald), AFP (YoProtein), CRP (Merck), his-tagged Ki67 (MyBiosource) were purchased from commercial sources. Unless otherwise specified, chemicals were purchased from Aldrich.
MALDI-MS and -MS/MS spectra were obtained using ultrafleXtreme TM TOF/TOF (Bruker).
Microwave-assisted CNBr-based cleavage reactions were performed by a household microwave oven (model R-248J, 800 W, 2450 MHz) from Sharp Inc. The PEAKS software was purchased from Bioinformatics Solutions Inc. The purification of bulk peptides was done by a preparative HPLC system from Gilson on a C 18 reversed phase preparative column (Kromasil ® from AkzoNobel, 5 µm, 250 × 30 mm). A mixture of 1 (7.17 g, 35.4 mmol) and (3-bromopropyl)trimethylammonium bromide (10.5 g, 40.0 mmol, 1.2 eq) in toluene (60 mL) was heated at 130˚C for 72 h under a nitrogen atmosphere. The mixture was cooled to room temperature and the solvent was decanted. The crude product was crystallized from methanol and methyl t-butyl ether to afford a pink powder, which was used in the next step without any purification.
Synthesis of ZWCy5
2) Synthesis of 3 2 A mixture of 1 (1.1 g, 3.97 mmol) and 6-iodohexanoic acid (0.98 g, 4.05 mmol, 1.1 eq) in 1,2-dichlorobenzene (10 mL) was heated at 110˚C overnight under a nitrogen atmosphere.
The mixture was cooled and solvent was decanted. Solid was triturated with 2-propanol until a free pink powder (0.63 g, 42%) was obtained, which was used in the next step without any purification.
3) Synthesis of ZWCy5
Malonaldehyde dianilide hydrochloride (17 mg, 66 µmol) is suspended in dry dichloromethane (100 µL). Then acetic anhydride (13 µL, 2 eq) and DIEA (11 µL, 1 eq) were added sequentially and the mixture is stirred at room temperature for 3 hours. was mixed with 5 molar equivalents of NHS-activated dye dissolved in DMSO (10 mg/ml).
The mixture was incubated for 1 h at room temperature under dark conditions. The dyelabeled hCAII was purified by using size exclusion chromatography. Upon purification the resulting dye-labeled hCAII was characterized by UV-vis spectroscopy and SDS-PAGE.
Protein concentration was determined by UV absorbance at 280 nm. With the desired sequence of peptide attained, the resin was treated in trifluoroacetic acid (95%), water (2.5%), and triisopropylsilane (2.5%) for 2 h. The cleavage cocktail was concentrated in a continuous flow of nitrogen, and the crude peptides were precipitated in diethyl ether. The resulting white solid was then purified to >95% in purity by HPLC bearing a C 18 reversed-phase preparative column. The purified peptides were used for affinity measurements via surface plasmon resonance (SPR) and confocal microscope image.
Affinity measurements. Affinity measurements were carried out on a Biacore T100 instrument (GE Healthcare). The CM5 sensor chip was used for all measurements. 
